These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 2473117)

  • 21. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection.
    Nayersina R; Fowler P; Guilhot S; Missale G; Cerny A; Schlicht HJ; Vitiello A; Chesnut R; Person JL; Redeker AG; Chisari FV
    J Immunol; 1993 May; 150(10):4659-71. PubMed ID: 7683326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extensive T cell receptor cross-reactivity on structurally diverse haptenated peptides presented by HLA-A2.
    Gagnon SJ; Turner RV; Shiue MG; Damirjian M; Biddison WE
    Mol Immunol; 2006 Feb; 43(4):346-56. PubMed ID: 16310048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 707-AP peptide recognized by human antibody induces human leukocyte antigen A2-restricted cytotoxic T lymphocyte killing of melanoma.
    Takahashi T; Irie RF; Nishinaka Y; Hoon DS
    Clin Cancer Res; 1997 Aug; 3(8):1363-70. PubMed ID: 9815820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A study of functionally active amino acids involved in the interaction of HLA-A2 or HLA-A3 molecules with cytolytic T lymphocytes.
    Healy F; Sire J; Gomard E; Yssel H; Jordan B; Levy JP
    J Immunol; 1988 Oct; 141(7):2487-96. PubMed ID: 2459213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymorphic HLA-DR7 beta 1 chain residues that are involved in T cell allorecognition.
    Rosen-Bronson S; Yu WY; Karr RW
    J Immunol; 1991 Jun; 146(12):4264-70. PubMed ID: 2040801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of stable CD4+ and CD8+ T cell lines from patients immunized with ras oncogene-derived peptides reflecting codon 12 mutations.
    Abrams SI; Khleif SN; Bergmann-Leitner ES; Kantor JA; Chung Y; Hamilton JM; Schlom J
    Cell Immunol; 1997 Dec; 182(2):137-51. PubMed ID: 9514698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural basis of Kbm8 alloreactivity. Amino acid substitutions on the beta-pleated floor of the antigen recognition site.
    Hunt HD; Pullen JK; Dick RF; Bluestone JA; Pease LR
    J Immunol; 1990 Sep; 145(5):1456-62. PubMed ID: 2384667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular analysis of an HLA-A2 functional variant CLA defined by cytolytic T lymphocytes.
    Ezquerra A; Doménech N; van der Poel J; Strominger JL; Vega MA; López de Castro JA
    J Immunol; 1986 Sep; 137(5):1642-9. PubMed ID: 3489037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implication of HLA-DR residues at positions 67, 71, and 86 in interaction between HLA-DR11 and peptide HA306-320.
    Zeliszewski D; Golvano JJ; Gaudebout P; Dorval I; Freidel C; Gebuhrer L; Betuel H; Borras-Cuesta F; Sterkers G
    J Immunol; 1993 Dec; 151(11):6237-47. PubMed ID: 7504016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two epitopes and one agretope map to a single HLA-A2 peptide recognized by H-2-restricted T cells.
    Martinon F; Cornille F; Gomard E; Fournie-Zaluski MC; Abastado JP; Roques BP; Levy JP
    J Immunol; 1989 May; 142(10):3489-94. PubMed ID: 2469716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Residues outside of the HLA-A2 peptide-binding groove can abrogate or enhance recognition of influenza virus matrix peptide pulsed cells by cytotoxic T lymphocytes.
    Teng JM; Hogan KT
    Mol Immunol; 1994 Apr; 31(6):445-57. PubMed ID: 8183283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delineation of determinants on HLA-B7 and HLA-B27 that are necessary for cytolytic T cell recognition by using inter- and intra-domain recombinants.
    Healy F; Toubert A; Gomard E; Jordan BR; Levy JP
    J Immunol; 1989 Oct; 143(7):2357-63. PubMed ID: 2476507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recognition of HLA-A2 mutant and variant target cells by an HLA-A2 allospecific human cytotoxic T lymphocyte line.
    Ware CF; Krangel MS; Pious D; Burakoff SJ; Strominger JL
    J Immunol; 1983 Sep; 131(3):1312-7. PubMed ID: 6193184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of mutations and variations of HLA-A2 on recognition of a virus peptide epitope by cytotoxic T lymphocytes.
    McMichael AJ; Gotch FM; Santos-Aguado J; Strominger JL
    Proc Natl Acad Sci U S A; 1988 Dec; 85(23):9194-8. PubMed ID: 2461564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of peptide sequences that potentially trigger HLA-A2.1-restricted cytotoxic T lymphocytes.
    Nijman HW; Houbiers JG; Vierboom MP; van der Burg SH; Drijfhout JW; D'Amaro J; Kenemans P; Melief CJ; Kast WM
    Eur J Immunol; 1993 Jun; 23(6):1215-9. PubMed ID: 7684681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unusual topology of an HLA-B27 allospecific T cell epitope lacking peptide specificity.
    Villadangos JA; Galocha B; López de Castro JA
    J Immunol; 1994 Mar; 152(5):2317-23. PubMed ID: 7510742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of mutant HLA-A2 molecules. Differential effects on peptide binding and CTL recognition.
    Tussey LG; Matsui M; Rowland-Jones S; Warburton R; Frelinger JA; McMichael A
    J Immunol; 1994 Feb; 152(3):1213-21. PubMed ID: 8301126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diversity and dominance among TCR recognizing HLA-A2.1+ influenza matrix peptide in human MHC class I transgenic mice.
    Man S; Ridge JP; Engelhard VH
    J Immunol; 1994 Nov; 153(10):4458-67. PubMed ID: 7963521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sequence motifs important for peptide binding to the human MHC class I molecule, HLA-A2.
    Parker KC; Bednarek MA; Hull LK; Utz U; Cunningham B; Zweerink HJ; Biddison WE; Coligan JE
    J Immunol; 1992 Dec; 149(11):3580-7. PubMed ID: 1331239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional assays of HLA A2-restricted epitope variant of latent membrane protein 1 (LMP-1) of Epstein-Barr virus in nasopharyngeal carcinoma of Southern China and Taiwan.
    Lin HJ; Cherng JM; Hung MS; Sayion Y; Lin JC
    J Biomed Sci; 2005 Dec; 12(6):925-36. PubMed ID: 16307312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.